Group 1 - The company plans to globally offer 360 million shares, with 25.22 million shares available in Hong Kong and 335 million shares internationally, along with an overallotment option of 54.05 million shares [1] - The subscription period for the shares is from June 13 to June 18, with a maximum offer price of HKD 22.53 per share and an entry fee of approximately HKD 2,275.72 for 100 shares [1] - The total expected fundraising amount is HKD 7.88 billion, with a net amount of HKD 7.74 billion, which will be used for ongoing global R&D and innovation, factory expansion in China, enhancing production automation, and strengthening digital infrastructure [1] Group 2 - The company's main business includes the research and development of household appliances, manufacturing of refrigeration and air conditioning equipment, and various types of valves and pumps [2] - The net profits for the years 2023, 2024, and the first quarter of 2025 (ending March 31) are projected to be CNY 2.92 billion, CNY 3.10 billion, and CNY 903 million, reflecting year-on-year changes of 13.51%, 6.10%, and 39.47% respectively [2]

Group 1 - The company plans to globally offer 10.5854 million H-shares, with 1.0586 million shares available in Hong Kong and 9.5268 million shares for international offering, along with a 15% over-allotment option [1] - The expected pricing range for the shares is HKD 18.9 to 20.9 per share, with a trading unit of 200 shares, and the shares are anticipated to start trading on June 10, 2025 [1] - The company is a leading producer of food-grade glycine and sucralose, holding the top position in the global food-grade glycine manufacturing industry based on sales volume and revenue in 2023, with a market share of approximately 5.1% in volume and 3.1% in revenue [2] Group 2 - The company has established cornerstone investment agreements with Reynold Lemkins Group (Asia) Limited and He Win Holdings Limited, agreeing to subscribe for shares up to HKD 60 million, with a total of 2.9848 million shares at a price of HKD 19.9 per share [3] - Assuming the over-allotment option is not exercised and the shares are priced at HKD 19.9, the total proceeds from the global offering are estimated to be approximately HKD 210.6 million, with net proceeds expected to be around HKD 174.3 million after listing expenses [4] - The intended use of the net proceeds includes approximately 21.3% for the construction of a production line for isomaltulose in Thailand, 55.3% for the production of algal dietary fiber and serine, 13.4% for enhancing R&D capabilities, and 10.0% for working capital and general corporate purposes [4]